Ethylene Glycol Intoxication: Case Report and Pharmacokinetic Perspectives

Pharmacotherapy

Volumn 23, Issue 12 I, 2003, Pages 1652-1658

  Vasavada, Nina ^a,c   Williams, Craig ^b   Hellman, Richard N ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Antidotes; Case report; Ethylene glycol; Poisoning; Renal dialysis

Indexed keywords

4 METHYLPYRAZOLE; ALCOHOL; ETHYLENE GLYCOL;

ADULT; ALCOHOL INTOXICATION; ARTICLE; CASE REPORT; DIURESIS; HEMODIALYSIS; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; MALE; METABOLIC ACIDOSIS;

ADULT; ANTIDOTES; ETHYLENE GLYCOL; HUMANS; MALE; POISONING; PYRAZOLES;

EID: 0345305406     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.15.1652.31968     Document Type: Article

References (16)

1. Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, et al. 2001 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2002;20:391-452.
2. Barceloux DG, Krenzelok EP, Olson K, Watson W. American Academy of Clinical Toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad hoc committee. J Toxicol Clin Toxicol 1999;37:537-60.
3. Jacobsen D, McMartin KE. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Toxicol 1997;35:127-43.
4. O'Neill B, Williams AF, Dubowski KM. Variability in blood alcohol concentrations: implications for estimating individual results. J Stud Alcohol 1983;44:222-30.
5. Burns MJ, Graudins A, Aaron CK, McMartin K, Brent J. Treatment of methanol poisoning with intravenous 4-methylpyrazole. Ann Emerg Med 1997;30:829-32.
6. Sivilotti ML, Burns MJ, McMartin KE, Brent J. Toxicokinetics of ethylene glycol during fomepizole therapy: implications for management. For the methylpyrazole for toxic alcohols study group. Ann Emerg Med 2000;36:114-25.
7. Orofino L, Marcen R, Quereda C, et al. Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients? Am J Nephrology 1990;10:177-80.
8. Hakim RM, Breillatt J, Lazarus JM, Port FK. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984;311:878-82.
9. Frantz SW, Beskitt JL, Tallant MJ, Zourelias LA, Ballantyne B. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fale after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat. Xenobiotica 1996;26:515-39.
10. Poldelski V, Johnson A, Wright S, Rosa VD, Zager RA. Ethylene glycol-mediated tubular injury: identification of critical metabolites and injury pathways. Am J Kidney Dis 2001;38:339-48.
11. Porter WH, Rutter PW, Bush BA, Pappas AA, Dunnington JE. Ethylene glycol toxicity: the role of serum glycolic acid in hemodialysis. J Toxicol Clin Toxicol 2001;39:607-15.
12. Moreau CL, Kerns W, Tomaszewski CA, et al. Glycolate kinetics and hemodialysis clearance in ethylene glycol poisoning. META study group. J Toxicol Clin Toxicol 1998;36:659-66.
13. McMartin KE, Cenac TA. Toxicity of ethylene glycol metabolites in normal human kidney cells. Ann N Y Acad Sci 2000;919:315-17.
14. Hirsch DJ, Jindal KK, Wong P, Fraser AD. A simple method to estimate the required dialysis time for cases of alcohol poisoning. Kidney Int 2001;60:2021-4.
15. Braden GL, Strayhorn CH, Germain MJ, Mulhern JG, Skutches CL. Increased osmolal gap in alcoholic acidosis. Arch Intern Med 1993;153:2377-80.
16. Borron SW, Megarbane B, Baud FJ. Fomepizole in treatment of uncomplicated ethylene glycol poisoning [letter]. Lancet 1999;354:831.